© 2004 Fellowship of Postgraduate Medicine
BEST PRACTICE
Subclinical hyperthyroidism: to treat or not to treat?
1 Department of Endocrinology, University Medical Center Nijmegen, Netherlands
2 Department of Cardiology, University Medical Center Nijmegen, Netherlands
Correspondence to:
Correspondence to:
Dr E H Hoogendoorn
Department of Endocrinology, University Medical Center Nijmegen, PO Box 9101, 6500 HB Nijmegen, The Netherlands; e.hoogendoorn{at}endo.umcn.nl
Subclinical hyperthyroidism may be defined as the presence of free thyroxine and tri-iodothyronine levels within the reference range and a reduced serum thyroid stimulating hormone (TSH) level. In this review the prevalence of low TSH in the population and health consequences of subclinical hyperthyroidism, for example, effects on heart and bone mass, are discussed. Guidelines for treatment are given, based on expert opinion.
Abbreviations: BMD, bone mineral density; TSH, thyroid stimulating hormone
Keywords: cardiac effects; osteoporosis; hyperthyroidism; subclinical hyperthyroidism
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
